BioCentury | Oct 6, 2020
Deals

Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more

...#), nivolumab (Generic), Opdivo (Other) sotorasib (AMG 510) lifileucel (LN-144, contego, TILs) omburtamab, 124I-8H9 (B7-H3), burtomab (8h9) Eidos Therapeutics BridgeBio Pharma Hugo Biotech Zhejiang...
Items per page:
1 - 1 of 1
BioCentury | Oct 6, 2020
Deals

Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more

...#), nivolumab (Generic), Opdivo (Other) sotorasib (AMG 510) lifileucel (LN-144, contego, TILs) omburtamab, 124I-8H9 (B7-H3), burtomab (8h9) Eidos Therapeutics BridgeBio Pharma Hugo Biotech Zhejiang...
Items per page:
1 - 1 of 1